March 2014 FDA Recall Drug by Hospira Inc.
D-1261-2014 - Presence of Particulate; red and black particulate within the solution and embedded within the plastic vial identified as iron oxide

This Class II drug recall was voluntarily initiated by Hospira Inc. on March 27, 2014 for the product Drug. The FDA reported the reason for recall as presence of particulate; red and black particulate within the solution and embedded within the plastic vial identified as iron oxide. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1261-2014

Reason for Recall
Presence of Particulate; red and black particulate within the solution and embedded within the plastic vial identified as iron oxide
Initiated
03-27-2014
Reported
04-30-2014
Quantity
255,900 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
67935
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Hospira Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
Nationwide
Termination Date About Termination Date
Date that FDA officially terminated the recall.
06-30-2015
Product Description About Product Description
Full technical description of the product.
Potassium Chloride for Inj. Concentrate, USP, 40 mEq (2 mEq/mL), 20 mL Single-dose Fliptop Vial, For IV use, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA

Batch or Lot Expiration Information

Lot# Lot 22-127-DK